ID :
30948
Tue, 11/18/2008 - 19:44
Auther :
Shortlink :
http://m.oananews.org//node/30948
The shortlink copeid
UK to help Indian companies produce cheaper AIDS drugs
London, Nov 18 (PTI) The United Kingdom is working with the Clinton Foundation to help Indian pharmaceutical companies produce cheaper drugs for malaria and AIDS.
The UK Secretary of State for International Development
Douglas Alexander MP announced this, saying the proposed nine
million pounds programme to be implemented between 2009 and
2012 would provide technical support to Indian companies in
producing and registering new treatments for AIDS and malaria,
and negotiate affordable prices for these drugs.
The move will help over 11 million people with AIDS
gain access to life saving treatment by 2012.
"Three million people died of HIV/AIDS in 2007, and
every year, there are over one million deaths from malaria,"
Alexander said.
Governments and private sector companies need to work
together to expand access to more effective and low cost
medicines to reduce this unacceptable burden, he said.
"Indian pharmaceutical companies have made a massive
contribution in improving the health of the poor, by providing
affordable drugs in India and to other developing countries.
We want to see their contribution grow, by reducing the
barriers they are facing in entering markets for newer and
more effective medicines for AIDS and malaria.
"It is a genuine win-win situation. With DFID
(Department for International Development) support to the
Clinton Foundation, health services for malaria and AIDS in
India and Africa will be able to buy drugs at cheaper prices
and put more people on better quality treatment, and
pharmaceuticals companies will enjoy a bigger market."
"The efforts of the Clinton HIV/AIDS Initiative have
enabled more than 70 countries around the world to have access
to affordable prices for HIV/AIDS drugs and diagnostics -
representing approximately 92 per cent of people living with
HIV globally," former US president and founder of Clinton
Foundation Bill Clinton said.
"We've also negotiated a 90 per cent reduction for
paediatric medicines around the world," he said and thanked
the UK for its efforts and support. PTI
The UK Secretary of State for International Development
Douglas Alexander MP announced this, saying the proposed nine
million pounds programme to be implemented between 2009 and
2012 would provide technical support to Indian companies in
producing and registering new treatments for AIDS and malaria,
and negotiate affordable prices for these drugs.
The move will help over 11 million people with AIDS
gain access to life saving treatment by 2012.
"Three million people died of HIV/AIDS in 2007, and
every year, there are over one million deaths from malaria,"
Alexander said.
Governments and private sector companies need to work
together to expand access to more effective and low cost
medicines to reduce this unacceptable burden, he said.
"Indian pharmaceutical companies have made a massive
contribution in improving the health of the poor, by providing
affordable drugs in India and to other developing countries.
We want to see their contribution grow, by reducing the
barriers they are facing in entering markets for newer and
more effective medicines for AIDS and malaria.
"It is a genuine win-win situation. With DFID
(Department for International Development) support to the
Clinton Foundation, health services for malaria and AIDS in
India and Africa will be able to buy drugs at cheaper prices
and put more people on better quality treatment, and
pharmaceuticals companies will enjoy a bigger market."
"The efforts of the Clinton HIV/AIDS Initiative have
enabled more than 70 countries around the world to have access
to affordable prices for HIV/AIDS drugs and diagnostics -
representing approximately 92 per cent of people living with
HIV globally," former US president and founder of Clinton
Foundation Bill Clinton said.
"We've also negotiated a 90 per cent reduction for
paediatric medicines around the world," he said and thanked
the UK for its efforts and support. PTI
